BrightPath Biotherapeutics
4594.TTSE GROWTHPharmaceutical
Filed as BrightPath Biotherapeutics Co., Ltd (2022-06–2026-06)
Major holders (5%+) · 0
| Holder | Stake |
|---|
No holder currently reports 5% or more.
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 4
| Phillip Securities Japan, Ltd. | 4.88% |
| Evo Fund | 4.62% |
| Macquarie Bank Limited | 1.84% |
| Evolution Capital Management LLC | 0.00% |
Ownership history · 51
| Holder | Ratio | Change |
|---|---|---|
| Phillip Securities Japan, Ltd.2026-02-19 | 4.88% | -1.41pp |
| Phillip Securities Japan, Ltd.2026-01-29 | 6.29% | -1.00pp |
| Phillip Securities Japan, Ltd.2026-01-21 | 7.29% | -1.95pp |
| Phillip Securities Japan, Ltd.2026-01-20 | 9.24% | -9.70pp |
| Phillip Securities Japan, Ltd.2026-01-06 · amended | 18.94% | -0.63pp |
| Phillip Securities Japan, Ltd2025-12-17 · amended | 19.57% | -0.23pp |
| Phillip Securities Japan, Ltd2025-12-17 · amended | 19.80% | new |
| Evolution Capital Management LLC2025-05-08 · amended | 0.00% | no change |
| Evo Fund2025-05-08 · amended | 18.14% | +13.30pp |
| Macquarie Bank Limited2024-07-26 · amended | 1.84% | -3.87pp |
| Macquarie Bank Limited2024-07-12 · amended | 5.71% | -5.21pp |
| Evolution Capital Management LLC2024-07-12 · amended | 0.00% | no change |
| Evo Fund2024-07-12 · amended | 4.84% | -3.51pp |
| Evolution Capital Management LLC2024-07-12 · amended | 0.00% | no change |
| Evo Fund2024-07-12 · amended | 8.35% | -3.19pp |
| Evolution Capital Management LLC2024-07-12 · amended | 0.00% | no change |
| Evo Fund2024-07-12 · amended | 11.54% | -4.57pp |
| Evolution Capital Management LLC2024-07-12 · amended | 0.00% | no change |
| Evo Fund2024-07-12 · amended | 16.11% | -1.18pp |
| Evolution Capital Management LLC2024-07-12 · amended | 0.00% | no change |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.